The Product Development Team at Third Pole Therapeutics is responsible for overseeing the design, development, and commercialization of innovative cardiopulmonary therapies. This team collaborates cross-functionally to ensure that the next generation of inhaled nitric oxide devices meets regulatory standards, aligns with market needs, and is delivered on time and within budget, all while prioritizing safety and efficacy for patients. Their work is pivotal in transforming therapeutic options and expanding access to life-saving treatments globally.
View all